| For: | Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19(47): 8887-8894 [PMID: 24379612 DOI: 10.3748/wjg.v19.i47.8887] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8887.htm |
| Number | Citing Articles |
| 1 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for Paradigm Change in Management of Hepatocellular Carcinoma: Is a Personalized Approach on the Horizon?. Personalized Medicine 2016; 13(5) doi: 10.2217/pme-2016-0013
|
| 2 |
Yue-qiu Zhang, Sai-nan Bian, Xiao-qing Liu, Shao-xia Xu, Li-fan Zhang, Bao-tong Zhou, Wei-hong Zhang, Yao Zhang, Ying-chun Xu, Guo-hua Deng. Positive Rate of Different Hepatitis B Virus Serological Markers in Peking Union Medical College Hospital, a General Tertiary Hospital in Beijing. Chinese Medical Sciences Journal 2016; 31(1) doi: 10.1016/S1001-9294(16)30017-7
|
| 3 |
Harald zur Hausen, Ethel-Michele de Villiers. Cancer “Causation” by Infections—Individual Contributions and Synergistic Networks. Seminars in Oncology 2014; 41(6) doi: 10.1053/j.seminoncol.2014.10.003
|
| 4 |
Wai-Kay Seto, Man-Fung Yuen. Clinical Epidemiology of Chronic Liver Diseases. 2019; doi: 10.1007/978-3-319-94355-8_8
|
| 5 |
Q.‐t. Huang, Q. Huang, M. Zhong, S.‐s. Wei, W. Luo, F. Li, Y.‐h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies. Journal of Viral Hepatitis 2015; 22(12) doi: 10.1111/jvh.12430
|
| 6 |
. 2019; doi: 10.70675/8d8b92bczb8bbz4bdbzb612zeba4d971f56a
|
| 7 |
Ke-Zhu Hou, Zhi-Qiang Fu, Hua Gong. Chemokine ligand 20 enhances progression of hepatocellular carcinoma <italic>via</italic> epithelial-mesenchymal transition. World Journal of Gastroenterology 2015; 21(2): 475-483 doi: 10.3748/wjg.v21.i2.475
|
| 8 |
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Sun Young Park, Joo Han Park, Jae Keun Kim, Hee Jung Wang, Jae Youn Cheong, Sung Won Cho. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. Cytokine 2015; 73(2) doi: 10.1016/j.cyto.2015.02.027
|
| 9 |
Wei Guo, Wei Tan, Shan Liu, Xuhui Huang, Juze Lin, Ronghua Liang, Le Su, Qiao Su, Changjun Wang. MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma. Tumor Biology 2015; 36(11) doi: 10.1007/s13277-015-3644-3
|
| 10 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38) doi: 10.1200/EDBK_200939
|
| 11 |
Ibrahim A. Naqid, Ahmed A. Mosa, Shah Vahel Ibrahim, Nizar Hussein Ibrahim, Nawfal R. Hussein, Mohamed Lounis. Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study. PLOS ONE 2023; 18(11) doi: 10.1371/journal.pone.0293822
|
| 12 |
. 2014; doi: 10.70675/a821800cz5289z4336z8ea8z35747d5bec05
|
| 13 |
Hua Dong, Lan Zhang, Ziliang Qian, Xuehua Zhu, Guanshan Zhu, Yunqin Chen, Xiaoying Xie, Qinghai Ye, Jie Zang, Zhenggang Ren, Qunsheng Ji. Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma. PLOS ONE 2015; 10(4) doi: 10.1371/journal.pone.0123175
|
| 14 |
Jia-Hong Liang, Qiao-Dong Xu, Song-Gang Gu. LncRNA RSU1P2-microRNA let-7a-Testis-Expressed Protein 10 axis modulates tumorigenesis and cancer stem cell-like properties in liver cancer. Bioengineered 2022; 13(2) doi: 10.1080/21655979.2022.2031394
|
| 15 |
Robert O. Dillman. Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?. Human Vaccines & Immunotherapeutics 2017; 13(3) doi: 10.1080/21645515.2016.1244149
|
| 16 |
Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma. Annals of Hepatology 2017; 16(4) doi: 10.5604/01.3001.0010.0290
|
| 17 |
Gaofeng Lu, Juan Antonio Villa, Maureen J. Donlin, Tiffany C. Edwards, Xiaohong Cheng, Richard F. Heier, Marvin J. Meyers, John E. Tavis. Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors. Antiviral Research 2016; 135 doi: 10.1016/j.antiviral.2016.09.009
|
| 18 |
Jotham Suez, Maayan Levy, Christoph A. Thaiss, Eran Elinav. Infection and Cancer: Bi-Directorial Interactions. 2015; doi: 10.1007/978-3-319-20669-1_9
|
| 19 |
Xuesong Deng, Jun Cheng, Naiyang Zhan, Jianwei Chen, Yongqiang Zhan, Yong Ni, Caixian Liao. MicroRNA‑135a expression is upregulated in hepatocellular carcinoma and targets long non‑coding RNA TONSL‑AS1 to suppress cell proliferation. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13069
|
| 20 |
Zain Ul Abedien, Kainat Gul, Sara Khan, Maheen Shafiq, Khizar Rahman, Muhammad Hassan Nawaz. Pathogenesis of Oncoviruses: A Systemic Review. Microbiology and Biotechnology Letters 2023; 51(2) doi: 10.48022/mbl.2303.03006
|
| 21 |
Qirun Wu, Xiaowei Chen, Peng Wang, Qiong Wu, Xun Qi, Xiangjun Han, Lufeng Chen, Xianwei Meng, Ke Xu. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 2020; 12(7) doi: 10.1021/acsami.9b22802
|
| 22 |
Huanfei Ding, Muhammad Fawad, Xiaolin Xu, Bowen Hu. A framework for identification and classification of liver diseases based on machine learning algorithms. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1048348
|
| 23 |
Lindsey A. Torre, Rebecca L. Siegel, Elizabeth M. Ward, Ahmedin Jemal. Global Cancer Incidence and Mortality Rates and Trends—An Update. Cancer Epidemiology, Biomarkers & Prevention 2016; 25(1) doi: 10.1158/1055-9965.EPI-15-0578
|
| 24 |
Vedika N. Dafe, Pooja R. Hatwar , Ravindra L. Bakal , Harshdeep V. Bindod. Hepatocellular Carcinoma: A Comprehensive Review of Pathophysiology, Risk Factors, Diagnosis and Treatment Strategies. Journal of Drug Delivery and Therapeutics 2025; 15(5) doi: 10.22270/jddt.v15i5.7123
|
| 25 |
Harald zur Hausen, Ethel-Michele de Villiers. Reprint of: Cancer “Causation” by Infections—Individual Contributions and Synergistic Networks. Seminars in Oncology 2015; 42(2) doi: 10.1053/j.seminoncol.2015.02.019
|
| 26 |
Weiqi Rong, Yang Zhang, Lei Yang, Lin Feng, Baojun Wei, Fan Wu, Liming Wang, Yanning Gao, Shujun Cheng, Jianxiong Wu, Ting Xiao. Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma. Frontiers of Medicine 2019; 13(2) doi: 10.1007/s11684-018-0632-1
|
| 27 |
Min Dai, Yue-Wu Yang, Wen-Hai Guo, Feng-Lin Wang, Ge-Min Xiao, Yang-Mei Li, Hong-Zhi Yang, Kieran Cooley. Addition and Subtraction Theory of TCM Using Xiao‐Chaihu‐Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4723530
|
| 28 |
Adélia Simão. Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib. GE Portuguese Journal of Gastroenterology 2016; 23(5) doi: 10.1016/j.jpge.2016.08.001
|
| 29 |
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populations. Radiology of Infectious Diseases 2015; 2(2) doi: 10.1016/j.jrid.2015.07.002
|
| 30 |
Yongxin Lin, Shan Liu, Le Su, Qiao Su, Juze Lin, Xuhui Huang, Changjun Wang. miR-570 Inhibits Proliferation, Angiogenesis, and Immune Escape of Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2018; 33(6) doi: 10.1089/cbr.2017.2389
|
| 31 |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang, Jia-Jie Zhang. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World Journal of Gastroenterology 2021; 27(17): 2025-2038 doi: 10.3748/wjg.v27.i17.2025
|
| 32 |
Zhimin Wang, Fang Li, Yuan Quan, Junye Shen. Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF‑κB/COX‑2/PPAR‑γ activities. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10198
|
| 33 |
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, Jacques Ferlay, Joannie Lortet‐Tieulent, Ahmedin Jemal. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015; 65(2) doi: 10.3322/caac.21262
|
| 34 |
JINSHENG WU, JINGLI HAN, BENXIN HOU, CHENGWEI DENG, HUANLIANG WU, LIANGFANG SHEN. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Oncology Reports 2016; 35(5) doi: 10.3892/or.2016.4638
|
| 35 |
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Min Jung Oh, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Min Jae Yang, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Sung Won Cho, Jae Youn Cheong. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib. Cytokine 2017; 95 doi: 10.1016/j.cyto.2017.02.020
|